ERK5-IN-1 exhibits potent inhibition of ERK5 with cellular EC50 values of 0.19 M and enzymatic IC50 values of 0.087 M and of LRRK2[G2019S] with enzymatic IC50 values of 0.026M.
For research use only. We do not sell to patients.
Name | ERK5-IN-1 |
---|---|
Iupac Chemical Name | ERK5-IN-1 |
Synonyms | 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-5,11-dimethyl- |
Molecular Formula | C25H29N7O2 |
Molecular Weight | 459.54 |
Smile | CN1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc4c(n3)N(c5ccccc5C(=O)N4C)C |
InChiKey | DDTPGANIPBKTNU-UHFFFAOYSA-N |
InChi | InChI=1S/C25H29N7O2/c1-29-11-13-32(14-12-29)17-9-10-19(22(15-17)34-4)27-25-26-16-21-23(28-25)30(2)20-8-6-5-7-18(20)24(33)31(21)3/h5-10,15-16H,11-14H2,1-4H3,(H,26,27,28) |
CAS Number | 1234479-76-5 |
MDL | MFCD18642659 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | crystalline solid |
---|---|
Purity | 98% |
Storage | 3 years -20ºCpowder |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |